ACTH therapy for West syndrome with severe hemophilia A

详细信息    查看全文

• 作者：Kazuo Kubota ; ^{kubotak-gif@umin.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Yoriko Kinomura ; Takahiro Yamamoto ; Michio Ozeki ; Minako Kawamoto ; Norio Kawamoto ; Toshiyuki Fukao
• 关键词：West syndrome ; Hemophilia A ; ACTH ; Coagulopathy
• 刊名：Epilepsy & Behavior Case Reports
• 出版年：2016
• 出版时间：2016
• 年：2016
• 卷：6
• 期：Complete
• 页码：1-2
• 全文大小：175 K

文摘

Hemophilia A is an X-linked recessive disorder caused by factor VIII deficiency, which is an important factor in the coagulation system. Here, we describe a 1-year-old boy with hemophilia A who developed West syndrome (WS). Recombinant factor VIII was administered during adrenocorticotropic hormone (ACTH) therapy to prevent intracranial hemorrhage. Infusion of factor VIII at fixed intervals is useful for the safe administration of ACTH therapy for patients with WS with severe hemophilia A. A coagulation screening test should be performed before ACTH therapy.